NYC-WTC_000195120

NYC 9/11 Public Portal Document

ASBESTOS HAZARDTEXT ® - Hazard Management Page 3 of 18

377. 47. Cavalieri A, Gobba F, Bacchella L et al: Serum type IH procollagen peptide in asbestos workers: an early indicator of pulmonary fibrosis. Br J Ind Med 1988; 45:818-823. 48. Chamberlain M & Tarmy EM: Asbestos and glass fibres in bacterial mutation tests. Mutat Res 1977;43:159-164. 49. Chang LY, Overby LH, Brody AR et al: Progressive lung cell reactions and extracellular matrix production after a brief exposure to asbestos. Am J Pathol 1988; 131:156-170. 50. ChemFab Corporation: Chemical Permeation Guide Challenge Protective Clothing Fabrics, Daniel Webster Highway, P.O. Box 1137, Merrimack, NH 03054 (800-451-6101). 51. Chemsoft(R): Electronic EPA, NIOSH, & OSHA Methods(TM). Windowchem(TM) Software, Fairfiled, CA, 1996. 52. CHRIS: CHRIS Hazardous Chemical Data. US Department of Transportation, US Coast Guard, Washington, DC (CD-ROM Version), Micromedex, Inc, Englewood, CO, 1990. 53. CHRIS: CHRIS Hazardous Chemical Data. US Department of Transportation, US Coast Guard, Washington, DC (CD-ROM Version), Micromedex, Inc, Englewood, CO, 1992. 54. CHRIS: CHRIS Hazardous Chemical Data. US Department of Transportation, US Coast Guard, Washington, DC (CD-ROM Version), Micromedex, Inc, Englewood, CO, 1995. 55. Churg A, Wright JL, Depaoli L et al: Mineralogic correlates of fibrosis in chrysotile miners and millers. Am Rev Respir Dis 1989; 139:891-896. 56. Churg A: The diagnosis of asbestosis. Human Pathol 1989; 20:97-99. 57. Clayton GD & Clayton FE (Eds): Patty's Industrial Hygiene and Toxicology, Volume 2A, Toxicology, 4th ed. John Wiley & Sons, New York, NY, 1993, pp 849-864. 58. Cleveland MG: Mutagenesis of Escherichia coli (CSH50) by asbestos. Proc Soc Exp Biol Med 1984; 177:343-346. 59. Coggon D, Inskip H, Winter P et al: Differences in occupational mortality from pleural cancer, peritoneal cancer, and asbestosis. Occup Environ Med 1995; 52:775-777. 60. Coliegeum Ramazzini: Call for an international ban on asbestos. Internal J Occup Environ Health 1999; 5:247-249. 61. Comasec Safety, Inc.: Product Literature, P.O. Box 1219, 8 Niblick Road, Enfield, CT 06082 (800-333-0219). 62. Constantopoulos SH, Theodoracopoulos P, Dascalopoulos G et al: Metsovo lung outside Metsovo. Endemic pleural calcifications in the ophiolite belts of Greece. Chest 1991; 99:1158- 1161. 63. Craighead JE: Do silica and asbestos cause lung cancer? Arch Pathol Lab Med 1992; 116:16- 20. 64. Crosignami P, Forastiere F, Petrelli G et al: Malignant mesothelioma in thermoelectric power plant workers in Italy. Am J Indus Med 1995; 27:573-576. 65. Cunningham HM & Pontemet RD: Nature 1974; 249:177-178. 66. Daniel FB: In vitro assessment of asbestos genotoxicity. Environ Health Perspect 1983; 53:163-167. 67. Dark DS & Pingleton SK: Asbestosis and asbestos-related disease. J Kansas Med Soc 1983; 84:392-396. 68. Davies D, Andrews MI & Jones JS: Asbestos induced pericardial effusion and constrictive pericarditis. Thorax 1991; 46:429-432. 69. de Klerk NH, Cookson WOC, Musk AW et al: Natural history of pleural thickening after exposure to crocidolite. Br J Ind Med 1989; 46:461-467. 70. de Klerk NH, Musk AW, Eccles JL et al: Exposure to crocidolite and the incidence of different histological types of lung cancer. Occup Environ Med 1996; 53:157-159. 71. Delclos GL, Flitcraft DG, Brousseau KP et al: Bronchoalveolar lavage analysis, gallium-67 lung scanning, and soluble interleukin-2 receptor levels in asbestos exposure. Environ Res

http://www.tomescps.com/DATA/DT/DT356-e.htm 1/4/2002

CITY_21MC100_012170713

NYC-WTC_000195147